General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy

Menopause

Volumn 8, Issue 4, 2001, Pages 290-295

  De Aloysio, D ^a   Di Donato, P ^a   Giulini, N A ^a   Modena, B ^a   Cicchetti, G ^a   Comitini, G ^a   Gentile, G ^a   Cristiani, P ^a   Careccia, A ^a   Esposito, E ^a   Gigli, C ^a   Mandruzzato, G ^a   Petraglia, F ^a   Bertelli, F ^a   Del Frate, G ^a   Garofalo, S ^a   Marino, L ^a   Costa, M R ^a   Qaranta, S ^a   Bossi, C M ^a   Amantea, P ^a   Omodei, U ^a   Vaccari, M ^a   Luerti, M ^a   Repetti, F ^a   Zandonini, G ^a   Raspagliesi, F ^a   Dolci, F ^a   Zacchi, V ^a   Bennici, S ^a   Polizzotti, G ^a   Bottino, S ^a   Raffaelli, F ^a   Minervini, C ^a   Colombo, D ^a   Belloni, C ^a   Viani, A ^a   Cecchini, G ^a   Winkler, S ^a   Samaja, B A ^a   Pasinetti, E ^a   Penotti, M ^a   Malanetto, C ^a   Massobrio, M ^a   Campagnoli, C ^a   Dolfin, G ^a   Tartaglino, P ^a   Mossotto, D ^a   Pesando, P ^a   Pacilli, L ^a   Rattazzi, P D ^a   Arisi, E ^a   Gamper, M ^a   Salvatores, D ^a   Bocchin, E ^a   Stellin, G ^a   Meli, G ^a   Azzini, V ^a   Tirozzi, F ^a   Buoso, G ^a   Fraioli, R ^a   Marsoni, V ^a   Cetera, C ^a   Sposetti, R ^a   Bellati, U ^a   Angeloni, C ^a   Buonerba, M ^a   Garzarelli, S ^a   Santilli, C ^a   Mucci, M ^a   Di Nisio, Q ^a   Falasca, L ^a   Ferrante, D ^a   Cirese, E ^a   Todaro, P A ^a   Romanini, C ^a   Spagnuolo, L ^a   Lanzone, A ^a   Donadio, C ^a   Fabiani, M ^a   Baldaccini, E ^a   Votano, S ^a   Serra, G B ^a   Bellardini, P ^a   Massacesi, L ^a   Donini, G ^a   Genazzani, R A ^a   Scarselli, G ^a   Curiel, P ^a   De Leo, V ^a   Melani, A ^a   Levi D'Ancona, V ^a   Giarre G ^a   Di Gioia, E ^a   Ciccarelli, P ^a   Donati Sarti, C ^a   Balsotti, G ^a   Pupita, P ^a   Parazzini, F ^a   more..

^a AOGOI   (Italy)

Author keywords

Determinants; Hormonal replacement therapy; HRT use

Indexed keywords

ESTROGEN;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; COUNSELING; DIABETES MELLITUS; EDUCATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENOPAUSE; NULLIPARA; OSTEOPENIA; OSTEOPOROSIS; OUTPATIENT;

EID: 0034932771     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200107000-00012     Document Type: Article

References (22)

1. Prevalence and determinants of estrogen replacement therapy in elderly women
2. Determinants of estrogen replacement therapy use in Northern Italy
3. Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers
4. Correlates of hormone replacement therapy use in Italian women 1992-1996
5. Sociological and behavioural characteristics of perimenopausal woman with an express attitude to hormone substitution therapy
6. A cross-sectional study of determinants of menopausal age and hormonal replacement therapy (HRT) use in Italian women
7. The antiestrogenic effect of cigarette smoking in women
8. A review of postmenopausal hormone therapy recommendations: Potential for selection bias
9. Are women using postmenopausal estrogens? A community survey
10. Correlates of postmenopausal female hormone use among black women in the United States
11. Replacement estrogen use and body mass index
12. Risk factors for genital prolapse in non-hysterectomized women around menopause: Resuits from a large cross-sectional study in menopausal clinics in Italy
13. Factors associated with HRT use in an Italian population. Book of Abstracts. The 9th International Menopause Society World Congress on the Menopause
14. Condizioni di salute e ricorso ai servizi sanitari (Anno 1994); Indagine multiscopo sulle famiglie (ISTAT). Informazioni
15. Agreement of self-reported use of menopausal hormone replacement therapy with physician reports
16. Socioeconomic status difference in hormone therapy
17. Hormone replacement therapy: Characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records
18. Determinants of first prescription of hormone replacement therapy: A follow-up study among 1689 women aged 54-60 years
19. Premenopausal determinants of menopausal estrogen use
20. Myocardial infaretion in women
21. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial